John McLaren-Howard

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history

John McLaren-Howard, DSc,[1] is the director of the Acumen Medical Limited, a laboratory in Devon, UK.[2] He is a Fellow of the American College of Nutrition.[1]

He was a co-author of the publication "Myalgic Encephalomyelitis – Adult & Paediatric: International Consensus Primer for Medical Practitioners," following the 2012 publication of the 2012 International Consensus Criteria (and co-written with many of the same authors of the latter).[1]

Notable studies[edit | edit source]

  • 2009, Chronic fatigue syndrome and mitochondrial dysfunction[3]
  • 2012, Mitochondrial dysfunction and the pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)[4]
  • 2013, Targeting mitochondrial dysfunction in the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) - a clinical audit[5]

References[edit | edit source]

  1. 1.0 1.1 1.2 Carruthers, BM; van de Sande, MI; De Meirleir, KL; Klimas, NG; Broderick, G; Mitchell, T; Staines, D; Powles, ACP; Speight, N; Vallings, R; Bateman, L; Bell, DS; Carlo-Stella, N; Chia, J; Darragh, A; Gerken, A; Jo, D; Lewis, DP; Light, AR; Light, KC; Marshall-Gradisnik, S; McLaren-Howard, J; Mena, I; Miwa, K; Murovska, M; Stevens, SR (2012), Myalgic encephalomyelitis: Adult & Paediatric: International Consensus Primer for Medical Practitioners (PDF), ISBN 978-0-9739335-3-6
  2. "Acumen Medical Limited". cqc.org.uk. Retrieved January 21, 2019.
  3. Myhill, S; Booth, NE; McLaren-Howard, J (January 15, 2009), "Chronic fatigue syndrome and mitochondrial dysfunction", International Journal of Clinical Experimental Medicine, 2 (1): 1–16, PMID 19436827
  4. Booth, NE; Myhill, S; McLaren-Howard, J (June 15, 2012), "Mitochondrial dysfunction and the pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)", International Journal of Clinical Experimental Medicine, 5 (3): 208–220, PMID 22837795
  5. Myhill, S; Booth, NE; McLaren-Howard, J (2013), "Targeting mitochondrial dysfunction in the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) - a clinical audit", International Journal of Clinical Experimental Medicine, 6 (1): 1–15, PMID 23236553